Timeline of Infringement and Revocation Actions Before the Unified Patent Court (UPC)
  • IP news
  • UP & UPC
  • Patents

Timeline of Infringement and Revocation Actions Before the Unified Patent Court (UPC)

Read more | Timeline of Infringement and Revocation Actions Before the Unified Patent Court (UPC)
Use of an infant formula for promoting growth is not a method of treatment by therapy
  • IP news
  • Patents

Use of an infant formula for promoting growth is not a method of treatment by therapy

Read more | Use of an infant formula for promoting growth is not a method of treatment by therapy
T2360/19 reasoning confirms the impact of G1/22 and G2/22 on formal priority in the Broad, MIT and Harvard CRISPR cases
  • Patents
  • IP news

T2360/19 reasoning confirms the impact of G1/22 and G2/22 on formal priority in the Broad, MIT and Harvard CRISPR cases

Read more | T2360/19 reasoning confirms the impact of G1/22 and G2/22 on formal priority in the Broad, MIT and Harvard CRISPR cases
G 1/24 : Enlarged Board of Appeal referral on claim interpretation
  • Patents
  • IP news

G 1/24 : Enlarged Board of Appeal referral on claim interpretation

Read more | G 1/24 : Enlarged Board of Appeal referral on claim interpretation
Ambush Marketing: How organizers rein in free riding on sports’ appeal
  • Trademarks
  • IP news

Ambush Marketing: How organizers rein in free riding on sports’ appeal

Read more | Ambush Marketing: How organizers rein in free riding on sports’ appeal
The impact of G1/22 and G2/22 on formal priority attacks by Opponents
  • Patents
  • IP news

The impact of G1/22 and G2/22 on formal priority attacks by Opponents

Read more | The impact of G1/22 and G2/22 on formal priority attacks by Opponents
Unitary Patents – A Numerical Journey in the European Patent Landscape
  • IP news
  • UP & UPC
  • Patents

Unitary Patents – A Numerical Journey in the European Patent Landscape

Read more | Unitary Patents – A Numerical Journey in the European Patent Landscape
Broader definition of “substance or composition” in medical use claims
  • IP news
  • Patents

Broader definition of “substance or composition” in medical use claims

Read more | Broader definition of “substance or composition” in medical use claims
Rejections of Requests for Unitary Effect – an update
  • IP news
  • UP & UPC

Rejections of Requests for Unitary Effect – an update

Read more | Rejections of Requests for Unitary Effect – an update
Romania Joins the UPCA
  • IP news
  • UP & UPC
  • Patents

Romania Joins the UPCA

Read more | Romania Joins the UPCA
Cloudy with a chance of patents: Vaping device prompts Enlarged Board of Appeal referral on using description to interpret claims
  • IP news
  • Patents

Cloudy with a chance of patents: Vaping device prompts Enlarged Board of Appeal referral on using description to interpret claims

Read more | Cloudy with a chance of patents: Vaping device prompts Enlarged Board of Appeal referral on using description to interpret claims
Flying high: 2023's record patent applications signal innovation boom
  • IP news
  • Patents

Flying high: 2023's record patent applications signal innovation boom

Read more | Flying high: 2023's record patent applications signal innovation boom
Grace period not always the saving grace
  • IP news
  • Trademarks

Grace period not always the saving grace

Read more | Grace period not always the saving grace
EPO clarifies implementation of new European Qualifying Exam
  • IP news
  • Patents

EPO clarifies implementation of new European Qualifying Exam

Read more | EPO clarifies implementation of new European Qualifying Exam
Changes in Requirements for Recording Transfers and Licensing Transactions of European Patent Applications
  • IP news
  • Patents

Changes in Requirements for Recording Transfers and Licensing Transactions of European Patent Applications

Read more | Changes in Requirements for Recording Transfers and Licensing Transactions of European Patent Applications
EPO rules that Broad Institute’s CRISPR patent priority is valid
  • IP news
  • Patents

EPO rules that Broad Institute’s CRISPR patent priority is valid

Read more | EPO rules that Broad Institute’s CRISPR patent priority is valid